Allowance Archives - Oregonmediacentral

1 min read

business classes

OSE Immunotherapeutics Receives European Patent Notice of Allowance For First-in-Class CD28-Antagonist Immunotherapy FR104

October 12, 2020 [email protected]_84

NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) announced the European Patent Office’s (EPO) issuance of a...

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Allowance

OSE Immunotherapeutics Receives European Patent Notice of Allowance For First-in-Class CD28-Antagonist Immunotherapy FR104

Online Bispecific Molecules in Oncology Analytical Handbook 2020

Premier League clubs reject Project Big Picture proposals

Celonis Acquires Integromat, an Industry Leading Online Automation Platform

Spicer mocks Pelosi claim of CNN being GOP ‘apologists’: ‘Had no idea I had Wolf Blitzer in my pocket’

OSE Immunotherapeutics Receives European Patent Notice of Allowance For First-in-Class CD28-Antagonist Immunotherapy FR104

You may have missed

Online Bispecific Molecules in Oncology Analytical Handbook 2020

Premier League clubs reject Project Big Picture proposals

Celonis Acquires Integromat, an Industry Leading Online Automation Platform

Spicer mocks Pelosi claim of CNN being GOP ‘apologists’: ‘Had no idea I had Wolf Blitzer in my pocket’